Related references
Note: Only part of the references are listed.Neoadjuvant therapy versus direct to surgery for T4 colon cancer: meta-analysis
Flora Jung et al.
BRITISH JOURNAL OF SURGERY (2022)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy
Shengnan Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer
Yuki Nakamura et al.
SCIENTIFIC REPORTS (2021)
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Aparna R. Parikh et al.
CLINICAL CANCER RESEARCH (2021)
Disease recurrence after colorectal cancer surgery in the modern era: a population-based study
Seyed M. Qaderi et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer
Thaer S. A. Abdalla et al.
PLOS ONE (2021)
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Dimitrios Mathios et al.
NATURE COMMUNICATIONS (2021)
Driver Gene Mutations and Epigenetics in Colorectal Cancer
Hans Raskov et al.
ANNALS OF SURGERY (2020)
Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction
Jee-Soo Lee et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
Huiyan Luo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Association of Observed Perioperative Cell-Free DNA Dynamics With Early Recurrence in Patients With Colon Cancer
Christina A. Fleming et al.
JAMA SURGERY (2020)
Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
Matteo Allegretti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA
Tenna V. Henriksen et al.
MOLECULAR ONCOLOGY (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
A First Step to a Biomarker of Curative Surgery in Colorectal Cancer by Liquid Biopsy of Methylated Septin 9 Gene
M. Leon Arellano et al.
DISEASE MARKERS (2020)
Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study
I. van den Berg et al.
BMC CANCER (2020)
Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers
Takeyuki Suzuki et al.
Oncotarget (2020)
Diagnostic and Prognostic Significance of MiR-150 in Colorectal Cancer: A Systematic Review and Meta-Analysis
Daniel Sur et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer A Systematic Review and Meta-analysis
Carolyn Cullinane et al.
JAMA NETWORK OPEN (2020)
Cell-free DNA as a biomarker for colorectal cancer: a retrospective analysis in patients before and after surgery
Liabing Zhong et al.
CELLULAR AND MOLECULAR BIOLOGY (2020)
Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
Young Kwang Chae et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
FOxTROT: an international randomised controlled trial in 1052 patients (pts) evaluating neoadjuvant chemotherapy (NAC) for colon cancer.
Matthew T. Seymour et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer
Yuxuan Wang et al.
JAMA ONCOLOGY (2019)
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert et al.
JAMA ONCOLOGY (2019)
The Efficacy of miR-20a as a Diagnostic and Prognostic Biomarker for Colorectal Cancer: A Systematic Review and Meta-Analysis
Laura Moody et al.
CANCERS (2019)
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
N. Tarazona et al.
ANNALS OF ONCOLOGY (2019)
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Jeanne Tie et al.
JAMA ONCOLOGY (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel
Vera Constancio et al.
CLINICAL EPIGENETICS (2019)
Staging with computed tomography of patients with colon cancer
M. L. Malmstrom et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)
Clinical applications of the CellSearch platform in cancer patients
Sabine Riethdorf et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer
Simon Ladefoged Rasmussen et al.
Oncotarget (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer
Lele Song et al.
BIOMARKERS IN MEDICINE (2018)
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
Julien Taieb et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
Julien Taieb et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients
Chiara Bedin et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Karen-Lise G. Spindler et al.
ONCOLOGIST (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
Aadel A. Chaudhuri et al.
CANCER DISCOVERY (2017)
DNA hypomethylation of CBS promoter induced by folate deficiency is a potential noninvasive circulating biomarker for colorectal adenocarcinomas
Geng Xue et al.
ONCOTARGET (2017)
The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer
Caroline Emilie B. Thomsen et al.
CANCER MEDICINE (2017)
Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping
Su-Jin Shin et al.
PLOS ONE (2017)
Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review
Chaogang Yang et al.
BMC CANCER (2017)
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Lone V. Scholer et al.
CLINICAL CANCER RESEARCH (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
Thomas Reinert et al.
GUT (2016)
Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
E. M. V. de Cuba et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Elevated Cell-Free DNA Measured by a Simple Assay Is Associated With Increased Rate of Colorectal Cancer Relapse
David Czeiger et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Andrew P. Feinberg et al.
NATURE REVIEWS GENETICS (2016)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer
Dimitrios Matthaios et al.
ONCOLOGY LETTERS (2016)
Fragment Length of Circulating Tumor DNA
Hunter R. Underhill et al.
PLOS GENETICS (2016)
Comment: The FAIR Guiding Principles for scientific data management and stewardship
Mark D. Wilkinson et al.
SCIENTIFIC DATA (2016)
Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer
A. C. R. K. Bos et al.
EUROPEAN JOURNAL OF CANCER (2015)
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array
Pei-Ching Lin et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands
Marloes A. G. Elferink et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2015)
Patterns of metachronous metastases after curative treatment of colorectal cancer
Yvette R. B. M. van Gestel et al.
CANCER EPIDEMIOLOGY (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Assessing Bias in Studies of Prognostic Factors
Jill A. Hayden et al.
ANNALS OF INTERNAL MEDICINE (2013)
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
U. K. Dion Morton et al.
LANCET ONCOLOGY (2012)
WITHDRAWN: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
International Journal of Surgery (2010)
Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence
Andreas Herbst et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies
Iveta Simera et al.
MATURITAS (2009)
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
Morten Braendengen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
The concentration of deoxyribonucleic acid in plasma from 73 patients with colorectal cancer and apparent clinical correlations
Hector Guadalajara et al.
CANCER DETECTION AND PREVENTION (2008)
Methylation of serum DNA is an independent prognostic marker in colorectal cancer
Maike Wallner et al.
CLINICAL CANCER RESEARCH (2006)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Molecular detection of APC, K-ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers
JY Wang et al.
WORLD JOURNAL OF SURGERY (2004)
Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis
T Lecomte et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Cell-free DNA: measurement in various carcinomas and establishment of normal reference range
TL Wu et al.
CLINICA CHIMICA ACTA (2002)
Share Paper
